Clinical and genetic analysis of an inherited case of thyroid adenoma/cancer

European Journal of Endocrinology

Volumn 137, Issue 4, 1997, Pages 360-364

  Asakawa, Hideki ^a   Kobayashi, Tetsuro ^a   Komoike, Yoshifumi ^a   Nakano, Yoshiaki ^a   Tamaki, Yasuhiro ^a   Matsuzawa, Yuji ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER FAMILY; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; HUMAN TISSUE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROTO ONCOGENE; SOUTHERN BLOTTING; THYROID ADENOMA; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOMA; ADOLESCENT; ADULT; BLOTTING, SOUTHERN; CHROMOSOME MAPPING; DROSOPHILA PROTEINS; FEMALE; GENES, P53; GENES, RETINOBLASTOMA; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; REPETITIVE SEQUENCES, NUCLEIC ACID; THYROID NEOPLASMS;

EID: 0030809676     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370360     Document Type: Article

References (25)

1. Goodfellow PJ & Wells SA. RET gene and its implications for cancer. Journal of the National Cancer Institute 1995 87 1515-1523.
2. Camiel MR, Mule JE, Alexander LL & Benninghoff DL. Association of thyroid carcinoma with Gardner's syndrome in siblings. New England Journal of Medicine 1968 268 1056-1059.
3. Stoffer SS, Van Dyke DL, Bach JV, Szpunar W & Weiss L. Familial papillary carcinoma of the thyroid. American Journal of Medical Genetics 1986 25 775-782.
4. Kobayashi K, Tanaka Y, Ishiguro S, Mori T, Mitani Y & Shigemasa C. Family with nonmedullary thyroid neoplasms. Journal of Surgical Oncology 1995 58 274-277.
5. Lote K, Andersen K, Nordal E & Brennhovd IO. Familial occurrence of papillary thyroid carcinoma. Cancer 1980 46 1291-1297.
6. Phade VR, Lawrence WR & Max MH. Familial papillary carcinoma of the thyroid. Archives of Surgery 1981 116 836-837.
7. Ron E, Kleinerman RA, LiVolsi VA & Fraumeni JF. Familial nonmedullary thyroid cancer. Oncology 1991 48 309-311.
8. Ozaki O, Ito K, Kobayashi K, Suzuki A, Manabe Y & Hosoda Y. Familial occurrence of differentiated, nonmedullary thyroid carcinoma. World Journal of Surgery 1988 12 565-571.
9. Yunis JJ. The chromosomal basis of human neoplasia. Science 1983 221 227-236.
10. Herrmann MA, Hay ID, Bartelt Jr DH, Ritland SR, Dahl RJ, Grant CS et al. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. Journal of Clinical Investigation 1991 88 1596-1604.
11. Boman BM. Biologic functions of the genes responsible for familial cancer. Current Opinion in Oncology 1994 6 90-95.
12. Takiguchi-Shirahama S, Koyama K, Miyauchi A, Wakasugi T. Oishi S, Takami H et al. Germline mutation of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia 2A. Human Genetics 1995 95 187-190.
13. Schubert EL, Hansen MF & Strong LC. The retinoblastoma gene and its significance. Annals of Medicine 1994 26 177-184.
14. Kloss K, Wahrisch P, Greger V, Messmer E, Fritze H, Hopping W et al. Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma. American Journal of Medical Genetics 1991 39 196-200.
15. Blanquet V, Creau-Goldberg N, Grouchy JD & Turleau C. Molecular detection of constitutional deletions in patients with retinoblastoma. American Journal of Medical Genetics 1991 39 355-361.
16. Eng C, Smith DP, Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ et al. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 1995 10 509-513.
17. Panza N, Del Vecchio L, Maio M, De Felice M, Lombardi G, Minozzi M et al. Strong association between a HLA-DR antigen and thyroid carcinoma. Tissue Antigens 1982 20 155-158.
18. Sridama V, Hara Y, Fauchet R & DeGroot LJ. Association of differentiated thyroid carcinoma with HLA-DR7. Cancer 1985 56 1086-1088.
19. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971 ii 971-972.
20. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene 1993 8 1913-1919.
21. Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989 4 159-164.
22. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH & Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. Journal of Clinical Investigation 1993 91 179-184.
23. Chen P, Iavarone A, Fick J, Edwards M, Prados M & Israel MA. Constitutional p53 mutations associated with brain tumors in young adults. Cancer Genetics and Cytogenetics 1995 82 106-115.
24. Lubbe J, Ammon KV, Watanabe K, Hegi ME & Kleihues P. Familial brain tumour syndrome associated with a p53 germline deletion of codon 236. Brain Pathology 1995 5 15-23.
25. Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni Jr J et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. American Journal of Human Genetics 1995 56 608-615.